Publication Date:
2011-11-28
Description:
The strain Escherichia coli Nissle 1917 (EcN) is widely used as an efficient probiotic in therapy and prevention of human infectious diseases, especially of the intestinal system. Concurrently, small adult pigs are being used as experimental omnivore models to study human gastrointestinal functions. EcN bacteria were applied to 6 adult healthy female pigs in a 2-week trial. 6 Control animals remained untreated. Altogether, 164 and 149 bacterial strains were isolated from smear samples taken from gastrointestinal mucosa in the experimental and control group, respectively. Each individual E. coli strain was then tested for the presence of 29 bacteriocin-encoding determinants as well as for DNA markers of A, B1, B2 and D phylogenetic groups. A profound reduction of E. coli genetic variance (from 32 variants to 13 ones, P = 0.0006) was found in the experimental group, accompanied by a lower incidence of bacteriocin producers in the experimental group when compared to control (21.3 and 34.9%, respectively; P = 0.007) and by changes in the incidence of individual bacteriocin types. The experimental administration of EcN strain was not sufficient for stable colonization of porcine gut, but induced significant changes in the enterobacterial microbiota. Content Type Journal Article Pages 1-6 DOI 10.1007/s00284-011-0051-x Authors David Šmajs, Department of Biology, Faculty of Medicine, Masaryk University, Kamenice 5, Building A6, 625 00 Brno, Czech Republic Jan Bureš, 2nd Department of Medicine, Faculty of Medicine at Hradec Králové, University Teaching Hospital, Charles University in Prague, Sokolská 581, 500 05 Hradec Kralove, Czech Republic Jan Šmarda, Department of Biology, Faculty of Medicine, Masaryk University, Kamenice 5, Building A6, 625 00 Brno, Czech Republic Eva Chaloupková, Department of Biology, Faculty of Medicine, Masaryk University, Kamenice 5, Building A6, 625 00 Brno, Czech Republic Jaroslav Květina, Institute of Experimental Biopharmaceutics, Joint Research Centre of Czech Academy of Sciences and PRO.MED.CS Praha a.s., Heyrovského 1207, 500 02 Hradec Kralove, Czech Republic Miroslav Förstl, Institute of Clinical Microbiology, Faculty of Medicine at Hradec Králové, University Teaching Hospital, Charles University in Prague, Sokolská 581, 500 05 Hradec Kralove, Czech Republic Darina Kohoutová, 2nd Department of Medicine, Faculty of Medicine at Hradec Králové, University Teaching Hospital, Charles University in Prague, Sokolská 581, 500 05 Hradec Kralove, Czech Republic Martin Kuneš, Institute of Experimental Biopharmaceutics, Joint Research Centre of Czech Academy of Sciences and PRO.MED.CS Praha a.s., Heyrovského 1207, 500 02 Hradec Kralove, Czech Republic Stanislav Rejchrt, 2nd Department of Medicine, Faculty of Medicine at Hradec Králové, University Teaching Hospital, Charles University in Prague, Sokolská 581, 500 05 Hradec Kralove, Czech Republic Jiřina Lesná, Institute of Clinical Microbiology, Faculty of Medicine at Hradec Králové, University Teaching Hospital, Charles University in Prague, Sokolská 581, 500 05 Hradec Kralove, Czech Republic Marcela Kopáčová, 2nd Department of Medicine, Faculty of Medicine at Hradec Králové, University Teaching Hospital, Charles University in Prague, Sokolská 581, 500 05 Hradec Kralove, Czech Republic Journal Current Microbiology Online ISSN 1432-0991 Print ISSN 0343-8651
Print ISSN:
0343-8651
Electronic ISSN:
1432-0991
Topics:
Biology
,
Medicine
Permalink